Nothing Special   »   [go: up one dir, main page]

Barrett et al., 2022 - Google Patents

Discovery solubility measurement and assessment of small molecules with drug development in mind

Barrett et al., 2022

Document ID
3549655963895270525
Author
Barrett J
Yang W
Skolnik S
Belliveau L
Patros K
Publication year
Publication venue
Drug discovery today

External Links

Snippet

Highlights•Seamless solubility understanding requires discovery-development collaboration.•Gold standard methods in drug development map solubility of drug candidates.•Drug development solubility informs developability and drug product …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G06F19/706Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/15Medicinal preparations; Physical properties thereof, e.g. dissolubility

Similar Documents

Publication Publication Date Title
Barrett et al. Discovery solubility measurement and assessment of small molecules with drug development in mind
O'Dwyer et al. In vitro methods to assess drug precipitation in the fasted small intestine–a PEARRL review
Lipert et al. Cocrystal transition points: role of cocrystal solubility, drug solubility, and solubilizing agents
Kuminek et al. Posaconazole cocrystal with superior solubility and dissolution behavior
Aitipamula et al. Polymorphs, salts, and cocrystals: what’s in a name?
Sun et al. Virtual coformer screening by crystal structure predictions: Crucial role of crystallinity in pharmaceutical cocrystallization
Denninger et al. A rational design of a biphasic dissolution setup—modelling of biorelevant kinetics for a ritonavir hot-melt extruded amorphous solid dispersion
Dai et al. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation
Chettri et al. Pharmaceutical co-crystals: A green way to enhance drug stability and solubility for improved therapeutic efficacy
Gan et al. Revisiting supersaturation of a biopharmaceutical classification system IIB drug: evaluation via a multi-cup dissolution approach and molecular dynamic simulation
Askin et al. Olanzapine form IV: Discovery of a new polymorphic form enabled by computed crystal energy landscapes
Kuentz et al. Rational selection of bio-enabling oral drug formulations–a PEARRL commentary
Stepanovs et al. Cocrystals of pentoxifylline: in silico and experimental screening
Polster et al. Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model
Guidetti et al. Exploring the cocrystal landscape of posaconazole by combining high-throughput screening experimentation with computational chemistry
Štoček et al. Importance of nuclear quantum effects for molecular cocrystals with short hydrogen bonds
Gan et al. Supersaturation and precipitation applicated in drug delivery systems: Development strategies and evaluation approaches
Bahr et al. Rapid screening approaches for solubility enhancement, precipitation inhibition and dissociation of a cocrystal drug substance using high throughput experimentation
Jeliński et al. Experimental and theoretical study on theobromine solubility enhancement in binary aqueous solutions and ternary designed solvents
Dash et al. Computational screening of multicomponent solid forms of 2-aryl-propionate class of NSAID, zaltoprofen, and their experimental validation
Sopyan et al. Co-crystallization: a tool to enhance solubility and dissolution rate of simvastatin
Jeliński et al. Quantification of Caffeine Interactions in Choline Chloride Natural Deep Eutectic Solvents: Solubility Measurements and COSMO-RS-DARE Interpretation
Niederquell et al. Hydroxypropyl cellulose for drug precipitation inhibition: from the potential of molecular interactions to performance considering microrheology
Koyama et al. Effect of seed particles on precipitation of weak base drugs in physiological intestinal conditions
Alinda et al. Nucleation of supersaturated flufenamic acid cocrystal solutions in the presence of a polymer